References
- Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Compar- ison of buprenorphine and methadone in the treatment of opioid dependence. Am J Psychiatry 1994; 151: 1025–30.
- Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2003;2:CD002207.
- Chiang CN, Hawks RL. Pharmacokinetics of the combina- tion tablet of buprenorphine and naloxone. Drug Alcohol Depend 2003;70(Suppl.): S39– 47.
- Mendelson J, Jones RT. Clinical and pharmacological evaluation of buprenorphine and naloxone combinations; why the 4:1 ratio for treatment? Drug Alcohol Depend 2003;70(Suppl.): S29– 37.
- Darke S, Ross J, Hall W. The injection of methadone syrup in Sydney, Australia. Technical Report no 23. Sydney: National Drug and Alcohol Research Centre, 1995.
- Darke S, Topp L, Ross J. The injection of methadone and benzodiazepines among Sydney injecting drug users 1996 – 2000: 5-year monitoring of trends from the Illicit Drug Reporting System. Drug Alcohol Rev 2002; 21: 27–32.
- Sunjic S, Zador DA. Methadone related deaths in New South Wales, July 1990 – December 1995. Drug Alcohol Rev 1999; 18: 409–16.
- Breen C, Degenhardt L, Roxburgh A et al. Australian Drug Trends 2002: findings of the Illicit Drug Reporting System. NDARC Monograph no. 50. Sydney: National Drug and Alcohol Research Centre, 2003.
- Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti J-P. Injecting misuse of buprenorphine among French drug users. Addiction 2001; 96: 267–72.
- Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther 1994; 55: 569–80.
- Auriacombe M, Franques P, Tignol J. Deaths attributable to buprenorphine vs methadone in France. JAMA 2001; 285: 45 – 6.
- Fudala P, Bridge PT, Herbert S et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine-naloxone. N Engl J Med 2003; 349: 949–58.
- Barau K, Thirion X, Micallef J, Chuniaud-Louche C, Bellemin B, San Marco J. Comparison of methadone and high dosage buprenorphine users in French care centres. Addiction 2001; 96: 1433–41.
- Mattick RP and the NEPOD study Group. National evaluation of pharmacotherapies for opioid dependence: report of results and recommendations. Sydney: National Drug and Alcohol Research Centre, 2001.
- Milby JB. Methadone maintenance to abstinence: how many make it? J Nerv Ment Dis 1988;176;409 – 22.
- Ball JC, Ross A. The effectiveness of methadone main- tenance treatment: patients, programs, services and out- come. New York: Springer-Verlag, 1991.
- Doran CM, Shanahan M, Mattick RP, Ali R, White J, Bell J. Buprenorphine versus methadone maintenance: a cost- effectiveness analysis. Drug Alcohol Depend 2003; 71: 295–302.